Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Steinacher

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Scientific Reports|March 19, 2025
Troponin is associated with mortality and significant coronary artery disease in patients treated for atrial fibrillation in the emergency departmentSophie Gupta, Eva Steinacher, Martin Lutnik, et al.
Journal of Clinical Medicine|June 28, 2023
The Impact of Preclinical High Potent P2Y<sub>12</sub> Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary SyndromeAndreas Hammer, Mario Krammel, Patrick Aigner, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 29, 2025
Beyond Obesity: Metabolic status as key driver for cardiovascular outcomes in patients undergoing invasive coronary angiographyEva Steinacher, Andreas Hammer, Ulrike Baumer, et al.
Journal of Women'S Health (2002)|August 28, 2023
Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart FailureAndreas Hammer, Felix Hofer, Niema Kazem, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 2024
Soluble ST2 is associated with postoperative atrial fibrillation after cardiac surgery in postmenopausal womenAndreas Hammer, Frieda Marka, Ulrike Baumer, et al.
Cardiorenal Medicine|September 26, 2025
The Prognostic Interplay of Heart Failure and Chronic Kidney Disease in Atrial Fibrillation - Focus on Cardiorenal OutcomesUlrike Baumer, Lea Pedarnig, Andreas Hammer, et al.
Journal of the American Heart Association|February 21, 2023
Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac SurgeryFelix Hofer, Andreas Hammer, Ulrike Pailer, et al.
Circulation. Cardiovascular Imaging|October 18, 2022
Hepatic T1-Time Predicts Cardiovascular Risk in All-Comers Referred for Cardiovascular Magnetic Resonance: A Post-Hoc AnalysisKatharina Mascherbauer, Carolina Donà, Matthias Koschutnik, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Scientific Reports|March 19, 2025
Troponin is associated with mortality and significant coronary artery disease in patients treated for atrial fibrillation in the emergency departmentSophie Gupta, Eva Steinacher, Martin Lutnik, et al.
Journal of Clinical Medicine|June 28, 2023
The Impact of Preclinical High Potent P2Y<sub>12</sub> Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary SyndromeAndreas Hammer, Mario Krammel, Patrick Aigner, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 29, 2025
Beyond Obesity: Metabolic status as key driver for cardiovascular outcomes in patients undergoing invasive coronary angiographyEva Steinacher, Andreas Hammer, Ulrike Baumer, et al.
Journal of Women'S Health (2002)|August 28, 2023
Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart FailureAndreas Hammer, Felix Hofer, Niema Kazem, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 2024
Soluble ST2 is associated with postoperative atrial fibrillation after cardiac surgery in postmenopausal womenAndreas Hammer, Frieda Marka, Ulrike Baumer, et al.
Cardiorenal Medicine|September 26, 2025
The Prognostic Interplay of Heart Failure and Chronic Kidney Disease in Atrial Fibrillation - Focus on Cardiorenal OutcomesUlrike Baumer, Lea Pedarnig, Andreas Hammer, et al.
Journal of the American Heart Association|February 21, 2023
Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac SurgeryFelix Hofer, Andreas Hammer, Ulrike Pailer, et al.
Circulation. Cardiovascular Imaging|October 18, 2022
Hepatic T1-Time Predicts Cardiovascular Risk in All-Comers Referred for Cardiovascular Magnetic Resonance: A Post-Hoc AnalysisKatharina Mascherbauer, Carolina Donà, Matthias Koschutnik, et al.
Pageof 2